Eagle Pharmaceuticals Inc (EGRX)
4.06
+0.21
(+5.45%)
USD |
NASDAQ |
Jun 17, 16:00
4.04
-0.02
(-0.49%)
After-Hours: 20:00
Eagle Pharmaceuticals Accounts Receivable (Quarterly): 115.14M for June 30, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 115.14M |
March 31, 2023 | 114.95M |
December 31, 2022 | 72.44M |
September 30, 2022 | 96.93M |
June 30, 2022 | 85.92M |
March 31, 2022 | 130.86M |
December 31, 2021 | 41.15M |
September 30, 2021 | 47.08M |
June 30, 2021 | 52.66M |
March 31, 2021 | 44.87M |
December 31, 2020 | 51.12M |
September 30, 2020 | 52.20M |
June 30, 2020 | 46.78M |
March 31, 2020 | 54.49M |
December 31, 2019 | 48.00M |
September 30, 2019 | 44.81M |
June 30, 2019 | 60.34M |
March 31, 2019 | 63.93M |
December 31, 2018 | 66.49M |
September 30, 2018 | 78.46M |
Date | Value |
---|---|
June 30, 2018 | 69.40M |
March 31, 2018 | 53.43M |
December 31, 2017 | 53.82M |
September 30, 2017 | 71.60M |
June 30, 2017 | 53.23M |
March 31, 2017 | 84.74M |
December 31, 2016 | 42.19M |
September 30, 2016 | 47.05M |
June 30, 2016 | 52.03M |
March 31, 2016 | 26.53M |
December 31, 2015 | 26.27M |
September 30, 2015 | 12.22M |
June 30, 2015 | 12.98M |
March 31, 2015 | 10.51M |
December 31, 2014 | 11.96M |
September 30, 2014 | 7.296M |
June 30, 2014 | 6.712M |
March 31, 2014 | 7.820M |
December 31, 2013 | 6.592M |
September 30, 2013 | 5.124M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
41.15M
Minimum
Dec 2021
130.86M
Maximum
Mar 2022
68.22M
Average
52.66M
Median
Jun 2021
Accounts Receivable (Quarterly) Benchmarks
Baxter International Inc | 2.521B |
Soligenix Inc | 0.117M |
Aldeyra Therapeutics Inc | -- |
Marinus Pharmaceuticals Inc | 3.513M |
BioXcel Therapeutics Inc | 0.378M |